mrna
(7)
The Copy Machine That Biology Forgot
For decades, scientists have hired bacteria to copy DNA. Elegen built a faster copy room with no cells inside - and turned a biological bottleneck into a six-day delivery business.
Moderna Designed Its COVID Vaccine in Two Days. The Hard Part Took Ten Years.
The Cambridge biotech turned messenger RNA from a lab curiosity into a platform for printing medicines from genetic code - vaccines, cancer shots, and rare-disease drugs that share one factory and swap out the instructions.
DNA Script
DNA Script is a French life-sciences technology company that pioneered Enzymatic DNA Synthesis (EDS) and built the SYNTAX System, the first benchtop DNA printer that lets researchers make custom DNA oligonucleotides on-site in hours instead of waiting days for outsourced orders. Founded in 2014 in Le Kremlin-Bicetre near Paris, the company aims to make biology programmable by putting rapid, template-free DNA production directly on the lab bench.
Portal Biotechnologies
Portal Biotechnologies is a Watertown, Massachusetts cell-engineering platform company building tools that push complex cargo - mRNA, siRNA, CRISPR complexes, proteins - into living cells by squeezing them through microscopic holes in a silicon surface, rather than relying on viruses or chemistry. Founded in 2023 by Armon Sharei, the MIT-trained scientist behind SQZ Biotechnologies, Portal sells hardware and consumables to drug discovery and cell therapy labs instead of developing its own drugs. Its instruments are used across more than 100 customer sites, including many of the world's largest pharmaceutical companies, and the company has raised seed and follow-on funding plus a DARPA contract for portable, point-of-care cell manufacturing.
HelixNano
HelixNano is a Cambridge/Boston-based biotechnology company building what it calls the world's most advanced mRNA platform - combining synthetic biology and machine learning to make vaccines and therapies that augment the immune system. Founded in 2014 by sci-fi novelist and mathematician Hannu Rajaniemi and synthetic biologist Nikolai Eroshenko, the Y Combinator-backed startup has pursued variant-resistant COVID-19 vaccine candidates and machine-learning-designed personalized cancer vaccines built on 'precision neoantigens'.
Strand Therapeutics
Strand Therapeutics is a clinical-stage biotech building 'programmable' mRNA medicines - drugs engineered with logic circuits so they switch on the right protein, in the right cell, at the right time. Spun out of MIT in 2017 by synthetic biologists who wrote the first programming language for mRNA, Strand's lead candidate STX-001 is a self-replicating mRNA that makes tumors manufacture their own IL-12, turning cold cancers hot from the inside. Backed by Kinnevik, Regeneron, Amgen and Eli Lilly with over $250M raised.
ReCode Therapeutics
ReCode Therapeutics is a clinical-stage genetic medicines company using its Selective Organ Targeting (SORT) lipid nanoparticle platform to deliver mRNA and gene-correction therapies beyond the liver. Its lead programs target cystic fibrosis and primary ciliary dyskinesia - rare respiratory diseases where existing modulators leave many patients without options.